Ratings
0
Nobody has rated this yet. Be the first!
Works
5
Abstract CT158: ATHENA (GOG-3020/ENGOT-ov45): a randomized, double-blind, placebo-controlled, Phase III study of rucaparib + nivolumab following front-line platinum-based chemotherapy in ovarian cancer
Low-Grade Serous Ovarian Cancer: Expert Consensus Report on the State of the Science
Fertility-sparing treatment in early endometrial cancer: current state and future strategies
Improving response to progestin treatment of low-grade endometrial cancer
Low-grade serous ovarian cancer: expert consensus report on the state of the science
